Toronto
Toronto
Toronto, British Columbia, Canada2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Active, not recruiting | Phase 2 | 2025-08-20 | NCT04015622 | |
| Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2) | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 2 / Phase 3 | 2025-02-24 | NCT03941132 |